JPH0358328B2 - - Google Patents

Info

Publication number
JPH0358328B2
JPH0358328B2 JP59263730A JP26373084A JPH0358328B2 JP H0358328 B2 JPH0358328 B2 JP H0358328B2 JP 59263730 A JP59263730 A JP 59263730A JP 26373084 A JP26373084 A JP 26373084A JP H0358328 B2 JPH0358328 B2 JP H0358328B2
Authority
JP
Japan
Prior art keywords
proglumide
analgesic
morphine
hydrochloride
methadone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59263730A
Other languages
English (en)
Japanese (ja)
Other versions
JPS60197619A (ja
Inventor
Robatei Ruiiji
Makobetsuku Furanchesuko
Senin Paoro
Kasura Pieeruruiji
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rottapharm SpA
Original Assignee
Rotta Research Laboratorium SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotta Research Laboratorium SpA filed Critical Rotta Research Laboratorium SpA
Publication of JPS60197619A publication Critical patent/JPS60197619A/ja
Publication of JPH0358328B2 publication Critical patent/JPH0358328B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP59263730A 1983-12-12 1984-12-12 プログルミドを含有する鎮痛剤組成物 Granted JPS60197619A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT68288/83A IT1160131B (it) 1983-12-12 1983-12-12 Proglumide composizioni e preparati farmaceutici che la comprendono per l'impiego nella terapia umana del dolore
IT68288A/83 1983-12-12

Publications (2)

Publication Number Publication Date
JPS60197619A JPS60197619A (ja) 1985-10-07
JPH0358328B2 true JPH0358328B2 (enExample) 1991-09-05

Family

ID=11308852

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59263730A Granted JPS60197619A (ja) 1983-12-12 1984-12-12 プログルミドを含有する鎮痛剤組成物

Country Status (6)

Country Link
US (1) US4576951A (enExample)
JP (1) JPS60197619A (enExample)
DE (1) DE3445183C2 (enExample)
FR (1) FR2556216B1 (enExample)
GB (1) GB2151136B (enExample)
IT (1) IT1160131B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ334627A (en) * 1999-03-12 2002-07-26 Horticulture & Food Res Inst A therapeutic composition containing a therapeutic agent such as an anthelmintic and an antistress agent such as metyrapone or a nitric oxide promoter for increasing efficacy of therapeutic agents and animal growth
US6835194B2 (en) * 1999-03-18 2004-12-28 Durect Corporation Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
US6541021B1 (en) 1999-03-18 2003-04-01 Durect Corporation Devices and methods for pain management
US7074803B2 (en) * 2001-03-02 2006-07-11 Durect Corporation Opioid formulations
US20040102476A1 (en) * 2002-11-25 2004-05-27 Chan Tai Wah High concentration formulations of opioids and opioid derivatives
WO2005011665A1 (en) * 2003-07-22 2005-02-10 Arakis Ltd. The use of proglumide for the treatment of emesis
GB0325957D0 (en) * 2003-11-06 2003-12-10 Arakis Ltd The treatment of pain
GB2481728B (en) * 2010-06-30 2012-05-23 Londonpharma Ltd Formulations and delivery devices for the sublingual administration of opioids
US8680145B1 (en) 2013-04-05 2014-03-25 College Of William And Mary Compositions and methods for treatment of fear of medical procedures
CN105213336B (zh) * 2015-10-14 2019-01-22 康普药业股份有限公司 一种丙谷胺药物组合物

Also Published As

Publication number Publication date
IT8368288A0 (it) 1983-12-12
FR2556216A1 (fr) 1985-06-14
DE3445183C2 (de) 1987-04-02
IT8368288A1 (it) 1985-06-12
FR2556216B1 (fr) 1990-12-07
GB2151136A (en) 1985-07-17
IT1160131B (it) 1987-03-04
GB2151136B (en) 1987-05-07
US4576951A (en) 1986-03-18
GB8430488D0 (en) 1985-01-09
JPS60197619A (ja) 1985-10-07
DE3445183A1 (de) 1985-06-13

Similar Documents

Publication Publication Date Title
CA1200501A (en) Nalbuphine - narcotic analgesic composition and method of producing analgesia
JP2000508341A (ja) 片頭痛の治療法及び薬効の強化組成物
KR19990067527A (ko) 동통의 치료를 위한 에피나스틴의 용도
US6703398B2 (en) Orally administered analgesic compositions containing nalbuphine
GB2271059A (en) Pharmaceutical compositions comprising aconitane derivatives
JPH0358328B2 (enExample)
EP0514023B1 (en) Use of glycine/NMDA receptor ligands for the manufacture of a medicament for the treatment of drug dependence and withdrawal
Huang et al. Comparative discriminative stimulus properties of dl-rmcathinone, d-amphetamine, and cocaine in rats
Wang et al. Alkaloids of Chinese aconitum plants
NO309965B1 (no) Oralt farmasøytisk antihostepreparat
MX2007003948A (es) Composicion farmaceutica en forma de tableta sublingual que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
AU689577B2 (en) New combination of a beta -receptor blocker and a local anaesthetic
KR20090125748A (ko) 대상포진 후 신경통 치료용 정제 및 대상포진 후 신경통의 치료 방법
JP2018515547A (ja) オピオイドとｎ−アシルエタノールアミンの組み合わせ
US5547956A (en) Pharmaceutical composition and the method for treating drug addicts' withdrawal syndromes and detoxifying addicts by the same
US2817623A (en) Tabernanthine, ibogaine containing analgesic compositions
SK164695A3 (en) Use of ropivacaine in the manufacture of a pharmaceutical agent with analgetic effect with minimal motor blockade
JPH045231A (ja) 慢性痛用鎮痛剤
JPS59116219A (ja) 中枢鎮痛剤とビタミンｂ１２又はその誘導体との組合せを活性成分として含む新規な鎮痛剤組成物
GB2189703A (en) Vinpocetine
KR20000029647A (ko) 양극성장애의치료방법
CA1141664A (en) Analgesic composition
RU2823100C2 (ru) Анальгетическая субстанция эндогенной природы, фармацевтическая композиция на ее основе и способы их применения
TWI893157B (zh) 具有嗎啡喃骨架之化合物或其藥理學上可容許之酸加成鹽的用途
JPH11513386A (ja) β−受容体遮断薬とオピオイドとの新規な組合せ物